Skip Navigation


IJE Advance Access originally published online on May 27, 2004
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
33/3/456    most recent
dyh121v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Vandenbroucke, J. P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vandenbroucke, J. P
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Journal of Epidemiology, Volume 33, Number 3, pp. 456-457
IJE vol.33 no.3 © International Epidemiological Association 2004; all rights reserved.

Commentary

Commentary: The HRT story: vindication of old epidemiological theory

Jan P Vandenbroucke

Department of Clinical Epidemioloy, Leiden University Medical Centre, Bldg 1 C9-P, 2300 RC Leiden, The Netherlands. E-mail: J.P.Vandenbroucke@lumc.nl

The first 10% of the full text of this article appears below.

In 1995, a long time before any result of any randomized controlled trial would be known, I wrote that about half of the alleged 35–45% reduction of myocardial infarction with hormone replacement therapy (HRT) in observational studies would not be real.1 Still, I should confess that the total reversal of the effect—a slight increase of myocardial infarction in the first years of use—took me also by surprise.

Why was I so certain that a large part of the seeming protection from myocardial . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin TrialsHome page
G. L. Anderson, C. Kooperberg, N. Geller, J. E. Rossouw, M. Pettinger, and R. L. Prentice
Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials
Clinical Trials, June 1, 2007; 4(3): 207 - 217.
[Abstract] [PDF]

Home page
 Int J EpidemiolHome page
J. Kim, S. Evans, L. Smeeth, and S. Pocock
Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age
Int. J. Epidemiol., June 1, 2006; 35(3): 731 - 738.
[Abstract] [Full Text] [PDF]

Home page
 J. Epidemiol. Community HealthHome page
N. Krieger, I. Lowy, R. Aronowitz, J. Bigby, K. Dickersin, E. Garner, J.-P. Gaudilliere, C. Hinestrosa, R. Hubbard, P. A Johnson, et al.
Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives
J Epidemiol Community Health, September 1, 2005; 59(9): 740 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
R. L. Prentice, R. Langer, M. L. Stefanick, B. V. Howard, M. Pettinger, G. Anderson, D. Barad, J. D. Curb, J. Kotchen, L. Kuller, et al.
Combined Postmenopausal Hormone Therapy and Cardiovascular Disease: Toward Resolving the Discrepancy between Observational Studies and the Women's Health Initiative Clinical Trial
Am. J. Epidemiol., September 1, 2005; 162(5): 404 - 414.
[Abstract] [Full Text] [PDF]

Home page
 Ann Fam MedHome page
C. van Weel
Longitudinal Research and Data Collection in Primary Care
Ann. Fam. Med, May 1, 2005; 3(suppl_1): S46 - S51.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
G. D. Smith
Classics in epidemiology: should they get it right?
Int. J. Epidemiol., June 1, 2004; 33(3): 441 - 442.
[Full Text] [PDF]